Compare CNTX & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTX | MKTW |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 55.9M |
| IPO Year | 2021 | 2020 |
| Metric | CNTX | MKTW |
|---|---|---|
| Price | $0.16 | $20.02 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | $3.79 | ★ $24.16 |
| AVG Volume (30 Days) | ★ 1.2M | 14.5K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 8.72% |
| EPS Growth | 17.39 | ★ 1183.33 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $512,403,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.59 |
| P/E Ratio | ★ N/A | $168.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.15 | $13.49 |
| 52 Week High | $3.62 | $23.00 |
| Indicator | CNTX | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 32.26 | 45.43 |
| Support Level | N/A | $19.19 |
| Resistance Level | $0.22 | $21.05 |
| Average True Range (ATR) | 0.02 | 0.85 |
| MACD | 0.00 | -0.22 |
| Stochastic Oscillator | 12.13 | 0.00 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.